ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
60,155.85
-5.77%
S&P 500
5,035.69
-1.57%
Dow Jones
37,815.92
-1.49%
US Dollar vs Yen
157.687
0.87%
Brent Oil
85.94
-1.54%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. ヨーロッパ
  5. EU
  6. Nanobiotix (NANO)

  7. Nanobiotix (NANO) ニュース

NANO

Nanobiotix (NANO)

Nanobiotix
から:
次の項目別のソート:
 Showing the most relevant articles for your search:EU:NANO
日付受信時刻ニュースソース見出しコード企業名
2023/07/1107 : 37Dow Jones NewsADRs End Mostly Lower, Nanobiotix and Taiwan Semiconductor Manufacturing Trade ActivelyEU:NANONanobiotix
2023/07/1020 : 37Dow Jones NewsECHO BOURSE: Nanobiotix bondit de 51% après un accord de licence avec JanssenEU:NANONanobiotix
2023/07/1019 : 57Dow Jones NewsNanobiotix Shares Soar on Licensing Deal With J&J UnitEU:NANONanobiotix
2023/05/0602 : 11Dow Jones NewsECHO BOURSE: Nanobiotix en négociation avec un grand laboratoire, l'action s'envoleEU:NANONanobiotix
2023/05/0602 : 06Dow Jones NewsECHO BOURSE: Nanobiotix en négociation avec un grand laboratoire, l'action s'envoleEU:NANONanobiotix
2019/07/1003 : 45GlobeNewswire Inc.Nanobiotix announces publication of phase III Soft Tissue Sarcoma data for first-in-class NBTXR3 in the Lancet OncologyEU:NANONanobiotix
2019/07/0115 : 00GlobeNewswire Inc.Nanobiotix announces new organizational structure as the company enters its next stage after first european market approvalEU:NANONanobiotix
2019/06/0415 : 00GlobeNewswire Inc.NANOBIOTIX APPOINTS NEW CHIEF MEDICAL OFFICER AS THE COMPANY EVOLVES AFTER ACHIEVEMENT OF EUROPEAN MARKET APPROVALEU:NANONanobiotix
2019/05/2814 : 00GlobeNewswire Inc.Nanobiotix announces the launch of curadigm : a new nanotechnology platform for healthcareEU:NANONanobiotix
2019/04/0501 : 31GlobeNewswire Inc.Nanobiotix Announces First Ever Radioenhancer to Receive European Market ApprovalEU:NANONanobiotix
2019/04/0301 : 56GlobeNewswire Inc.Combination of first-in-class NBTXR3, radiotherapy, and anti-PD-1 immunotherapy demonstrate efficacy in treating resistant pr...EU:NANONanobiotix
2019/03/2616 : 00GlobeNewswire Inc.Nanobiotix announces its clinical registration plan in Head and Neck cancers for the United States following FDA feedbackEU:NANONanobiotix
2019/03/1602 : 40GlobeNewswire Inc.Nanobiotix 2018 Annual ResultsEU:NANONanobiotix
2018/11/1521 : 00GlobeNewswire Inc.Nanobiotix revenues for the 3rd quarter of 2018EU:NANONanobiotix
2018/10/1921 : 05GlobeNewswire Inc.NANOBIOTIX: Positive phase II/III results for NBTXR3 in Soft Tissue Sarcoma presented at ESMOEU:NANONanobiotix
2018/10/1611 : 13GlobeNewswire Inc.Nanobiotix receives first tranche disbursement of 16 million euros financing from European Investment BankEU:NANONanobiotix
2018/09/2611 : 00GlobeNewswire Inc.Nanobiotix to present positive results from its phase II/III clinical trial of NBTXR3 in patients with Soft Tissue Sarcoma (S...EU:NANONanobiotix
2018/09/2011 : 04GlobeNewswire Inc.Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018EU:NANONanobiotix
2018/09/0501 : 20GlobeNewswire Inc.NANOBIOTIX half year results for the six months ended June 30, 2018EU:NANONanobiotix
2018/07/2701 : 32GlobeNewswire Inc.NANOBIOTIX signs a 40 M€ non-dilutive financing agreement with the European Investment BankEU:NANONanobiotix
2018/06/2221 : 29Dow Jones NewsNanobiotix offre un succès bienvenu pour relancer les biotechs tricolores - DJ PlusEU:NANONanobiotix
2018/06/2202 : 41GlobeNewswire Inc.NANOBIOTIX announces positive phase II/III topline data in soft tissue sarcoma with NBTXR3EU:NANONanobiotix
2018/06/0622 : 55GlobeNewswire Inc.NANOBIOTIX' Management statement on recent share price variationEU:NANONanobiotix
2018/05/1415 : 57Cercle FinanceCalendrier des sociétés sur 15 joursEU:NANONanobiotix
2018/05/0402 : 35GlobeNewswire Inc.Nanobiotix partners with Weill Cornell Medicine on pre-clinical studies to evaluate the impact of NBTXR3 on cGAS-STING pathwa...EU:NANONanobiotix
2018/04/1803 : 01GlobeNewswire Inc.AACR annual meeting 2018: Nanobiotix presented preclinical data showing NBTXR3 nanoparticles can activate the cGAS-STING path...EU:NANONanobiotix
2018/04/1116 : 01Cercle FinanceNanobiotix: projet de recherche avec le MD AndersonEU:NANONanobiotix
2018/04/1103 : 42GlobeNewswire Inc.NANOBIOTIX : THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER AND NANOBIOTIX HAVE AN AGREEMENT TO RUN IMMUNOTHERAPEUTIC PRE-...EU:NANONanobiotix
2018/03/3023 : 03GlobeNewswire Inc.NANOBIOTIX : Nanobiotix 2017 Annual ResultsEU:NANONanobiotix
2018/03/2616 : 12Cercle FinanceCalendrier des sociétés sur 15 joursEU:NANONanobiotix
 Showing the most relevant articles for your search:EU:NANO

最近閲覧した銘柄

USOTC
BNPQY
BNP Paribas (QX)
NYSE
DIS
Walt Disney
CCOM
US100
US Tech 100
USOTC
BASFY
BASF (QX)
NYSE
KO
Coca Cola
FX
USDGBP
US Dollar vs Sterling
USI
USTECH100
US Tech 100
NASDAQ
NVDA
NVIDIA
AMEX
XLE
Energy Select Sector SPDR
USOTC
ADDYY
Adidas (QX)
SPI
SP500
S&P 500
NASDAQ
TSLA
Tesla
AMEX
XLV
Health Care Select Sector
NYSE
MCD
McDonalds
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有